Related Experiment Video
Updated: Feb 16, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Inflammatory and Neuropathic Pain From Bench to Bedside: What Went Wrong?
Robert P Yezierski1, Per Hansson2
1Pain Research and Intervention Center of Excellence and Department of Orthodontics, University of Florida, Gainesville, Florida.
Abstract:
In recent years, the disappointing history of translation in pain research has undergone significant scrutiny. The escalation of knowledge and understanding related to presumed pain in neuropathic and inflammatory animal models contrasted with the unsatisfactory record of "bench-to-bedside" translation has raised many questions about the validity and clinical relevance of preclinical models and methods of behavioral assessment. Although many opinions have been expressed one of the overriding concerns and greatest barriers to the widening gap between preclinical research and the development of new interventions has been the underappreciated distinction between pain and nociception. As a result of these shortcomings, the distance between mechanism-based research and patient-centered product development has been referred to as the "valley of death." The reasons for the disappointing record of translation are many and easy to point out, but the changes needed and the strategies necessary to accomplish translational goals are much more difficult to identify. One of the challenges of translational pain research that has garnered a lot of attention relates to strategies of behavioral assessment which, with few exceptions, has remained basically unchanged for more than 3 decades. Other issues important to the discussion include but are not limited to the predictive validity of preclinical models, and the neglect of gender, age, and comorbidities in the design of preclinical studies. On the clinical side, the lack of sanitization of phenotypes in clinical trials has also contributed to the insufficient success of efforts to translate basic research to the clinic. The current review will discuss these and other issues believed to have contributed to the existing obstacles and challenges facing pain research along with making recommendations for the future.
Perspective:
In this review the challenges of preclinical pain research and the reasons for the disappointing record of translation are examined. Important to this discussion is recognizing the scope of clinical characteristics associated with chronic pain conditions and the need for more clinically relevant models and methods of pain assessment.
More Related Videos
10:52Chronic Constriction Injury of the Rat's Infraorbital Nerve IoN-CCI to Study Trigeminal Neuropathic Pain
Published on: September 21, 2015
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Pain
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Analgesia and Pain Management
Inflammatory Response I: Vascular and Cellular
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...